3.5 Cannabis, Hallucinogens, and Inhalants

Cannabis, hallucinogens, and inhalants: do not minimize impairment

Cannabis, hallucinogens, and inhalants do not look identical on the exam, but they share a common testing theme: altered perception and judgment can create real risk. A CADC should avoid minimizing these substances just because one is common, one is episodic, or one does not fit a stereotyped picture of addiction.

Cannabis may involve relaxation, altered time perception, impaired attention, anxiety, panic, increased appetite, and impaired driving. Heavy or frequent use can affect motivation, memory, school, work, and relationships. Some clients report withdrawal-like symptoms such as irritability, sleep disturbance, appetite change, and craving.

Hallucinogens can produce perceptual changes, unusual beliefs, emotional swings, panic, and impaired judgment. The counseling skill is not to argue the client out of a perception during acute distress. A calmer response is to reduce stimulation, maintain safety, assess orientation and risk, and seek medical or crisis consultation if danger appears.

Inhalants deserve special caution. They may be used by adolescents or adults because products are accessible, cheap, and legal for ordinary household purposes. The exam trap is to dismiss inhalants as experimentation. Inhalant use can be associated with acute medical danger, injury, cognitive effects, and sudden emergencies.

Applied scenario: an adolescent is brought in after huffing aerosol products at school and laughing it off as not real drugs. The best CADC response is to assess acute medical safety, frequency, access, peer context, family supervision, and need for referral. It is not enough to say the behavior is normal adolescent curiosity.

Another scenario: an adult uses high-potency cannabis daily and reports panic attacks, poor sleep, and job problems. A strong answer acknowledges both substance-use and mental health concerns without making a diagnosis beyond the counselor role. Screen, assess functioning, provide education, and refer when symptoms require mental health evaluation.

Exam trap: assuming legality decides clinical importance. IC&RC ADC questions are about competencies for addressing substance use and addiction, not about whether a jurisdiction permits possession. Legal status does not remove impairment, risk, or treatment need.

Use careful language in documentation. Record what the client used, route if known, amount if known, last use, observed behavior, reported effects, safety questions, and referrals. Avoid vague phrases such as acted weird without observable detail.

Review list for these groups:

• Cannabis can impair driving, learning, attention, and emotional regulation.
• Hallucinogens can create panic and unsafe behavior during intoxication.
• Inhalants are high risk and should not be treated as harmless experimentation.
• Synthetic or unknown products can produce unpredictable symptoms.
• CADCs use assessment, engagement, referral, and case coordination.